24 June 2019


Socially Responsible Licensing at Oncode Institute

Elize Brolsma

Innovation in health care solutions has been seen to correlate with increased costs, potentially resulting in unaffordable health care in the future. One of the ways that Oncode is planning for sustainable implementation of research outputs from the very beginning is through implementation of the Socially Responsible Licensing policies.

It is important that our research results are translated into an application as quickly as possible. When research institutions work together with commercial parties, then often grant licenses to companies on an invention made by their researchers. In consultation with many partners, The Netherlands Federation of University Medical Centres (NFU) established a working group that formulated ten principles for socially responsible licensing.

Oncode has been part of the working group, formally endorses these principles and will implement these guidelines to make sure new scientific insights will be translated into novel therapies for patients in a responsible way.

You can find the 10 principles for socially responsible licensing here (in Dutch).

Other News

Louis Vermeulen
Inaugural lecture Louis Vermeulen
On Friday, September 6th, 2019, Oncode Investigator Louis Vermeulen (Amsterdam UMC, location AMC) will give his inaugural lecture to officially accept his position as newly appointed professor of Molecular Oncology. This event will take place at 4pm at the Aula der Universiteit (Singel 411, corner Spui) and is followed by a reception. The Oncode community is invited to be present at this ceremony.
Miao-Ping Chien: ‘What I’ve learned from the LSW Venture Challenge’
The Life Sciences at Work Venture Challenge is a 10-week programme to develop an initial idea – a breakthrough research result – into a solid business case. Miao-Ping Chien, Oncode Investigator and group leader at Erasmus MC, is one of the few researchers who was given the opportunity to participate. Oncode Institute talks to her about the insights she gained following this program.
Mario Van Der Stelt
Research Management Committee welcomes new member Mario van der Stelt
We are pleased to announce that Mario van der Stelt (Leiden University) is now part of Oncode’s Research Management Committee. Mario brings the Leiden flavour to the RMC and has a wealth of experience in medicinal chemistry, drug discovery and chemical biology.